Azenta Inc at JPMorgan Healthcare Conference Transcript
Hello, everyone. Good morning. Thank you for coming. My name is Zach Conte. I'm a member of the health care investment banking team here at JPMorgan. It's my pleasure to introduce Azenta Life Sciences. Today, we're joined by Stephen Schwartz, CEO. There will be a presentation followed by a short Q&A. Thank you.
Thank you, Zach. Good morning, everyone. It's great to see you here. Just let me start. We're delighted to have a chance, again, to present here at the JPMorgan Healthcare Conference. I'm proud to represent about 4,000 employees worldwide from Azenta who are really focused on delivering on our purpose to enable breakthroughs faster. I'd love to convey just a short summary of where we are as a company, catch up a little bit from the report we had last quarter and also talk about the future as we see it. Toward that end, I will be making forward-looking statements. I just want to remind everyone, call your attention to our safe harbor statement at
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |